U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07106112) titled 'Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy' on July 24.

Brief Summary: This single-center, randomized study aims to compare the intraoperative detection rates of axillary lymph nodes marked with carbon suspension versus metallic markers in breast cancer patients (T1-3N1M0) before neoadjuvant therapy. Primary endpoint: frequency of marked lymph node identification during surgery. Secondary endpoints: time from marking to surgery and quality of life (EORTC QLQ-BR23).

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: PROC...